Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Change in Cash: 2020-2024

Historic Change in Cash for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$7.1 million.

  • Journey Medical's Change in Cash rose 420.81% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 208.70%. This contributed to the annual value of -$7.1 million for FY2024, which is 56.31% down from last year.
  • As of FY2024, Journey Medical's Change in Cash stood at -$7.1 million, which was down 56.31% from -$4.6 million recorded in FY2023.
  • Journey Medical's 5-year Change in Cash high stood at $40.8 million for FY2021, and its period low was -$17.1 million during FY2022.
  • Over the past 3 years, Journey Medical's median Change in Cash value was -$7.1 million (recorded in 2024), while the average stood at -$9.6 million.
  • As far as peak fluctuations go, Journey Medical's Change in Cash skyrocketed by 1,085.34% in 2021, and later tumbled by 141.82% in 2022.
  • Journey Medical's Change in Cash (Yearly) stood at $3.4 million in 2020, then spiked by 1,085.34% to $40.8 million in 2021, then slumped by 141.82% to -$17.1 million in 2022, then surged by 73.28% to -$4.6 million in 2023, then tumbled by 56.31% to -$7.1 million in 2024.